179 related articles for article (PubMed ID: 28959434)
1. Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review.
Sawicka M; Tracy DK
Ther Adv Psychopharmacol; 2017 Sep; 7(8-9):211-224. PubMed ID: 28959434
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Treatment of Alcohol use Disorder in Patients with Psychotic Disorders: A Systematic Review.
Rosenstand NJ; Nielsen AS; Skøt L; Anhøj S; Nielsen DG; Højlund M; Mellentin AI
Curr Neuropharmacol; 2024; 22(6):1129-1143. PubMed ID: 36582063
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
[TBL] [Abstract][Full Text] [Related]
4. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
[TBL] [Abstract][Full Text] [Related]
5. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence.
Anton RF; Latham PK; Voronin KE; Randall PK; Book SW; Hoffman M; Schacht JP
Alcohol Clin Exp Res; 2018 Apr; 42(4):751-760. PubMed ID: 29431852
[TBL] [Abstract][Full Text] [Related]
6. Veteran adherence to oral versus injectable AUD medication treatment.
Stewart H; Mitchell BG; Ayanga D; Walder A
Ment Health Clin; 2021 May; 11(3):194-199. PubMed ID: 34026395
[TBL] [Abstract][Full Text] [Related]
7. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
Capone C; Kahler CW; Swift RM; O'Malley SS
J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
Petrakis IL; O'Malley S; Rounsaville B; Poling J; McHugh-Strong C; Krystal JH;
Psychopharmacology (Berl); 2004 Mar; 172(3):291-7. PubMed ID: 14634716
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
Jonas DE; Amick HR; Feltner C; Bobashev G; Thomas K; Wines R; Kim MM; Shanahan E; Gass CE; Rowe CJ; Garbutt JC
JAMA; 2014 May; 311(18):1889-900. PubMed ID: 24825644
[TBL] [Abstract][Full Text] [Related]
10. Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone.
Roos CR; Mann K; Witkiewitz K
Addict Biol; 2017 Nov; 22(6):1528-1539. PubMed ID: 27480445
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
Palpacuer C; Duprez R; Huneau A; Locher C; Boussageon R; Laviolle B; Naudet F
Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C; Angeles M; Muñoz A; Amate JM
Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
[TBL] [Abstract][Full Text] [Related]
13. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
[TBL] [Abstract][Full Text] [Related]
14. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
Soyka M; Rösner S
Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
[TBL] [Abstract][Full Text] [Related]
15. Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies.
Florence L; Lassi DLS; Kortas GT; Lima DR; de Azevedo-Marques Périco C; Andrade AG; Torales J; Ventriglio A; De Berardis D; De Aquino JP; Castaldelli-Maia JM
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326342
[TBL] [Abstract][Full Text] [Related]
16. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
Petrakis IL; Nich C; Ralevski E
Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
Garbutt JC; Kranzler HR; O'Malley SS; Gastfriend DR; Pettinati HM; Silverman BL; Loewy JW; Ehrich EW;
JAMA; 2005 Apr; 293(13):1617-25. PubMed ID: 15811981
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone: A Pan-Addiction Treatment?
Aboujaoude E; Salame WO
CNS Drugs; 2016 Aug; 30(8):719-33. PubMed ID: 27401883
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
